Literature DB >> 2682960

Neurologic manifestations of Lyme disease, the new "great imitator".

A R Pachner1.   

Abstract

The causative agent of Lyme disease, Borrelia burgdorferi, is a highly neurotropic organism that not only can produce symptomatic neurologic disease but also can exist dormant within the central nervous system (CNS) for long periods. Two distinct types of neuroborreliosis occur at different stages of Lyme disease. Second-stage Lyme meningitis resembles aseptic meningitis and is often associated with facial palsies, peripheral nerve involvement, and/or radiculopathies. Lyme meningitis may be the first evidence of Lyme disease, occurring without a history of erythema chronicum migrans or flu-like illness. Third-stage parenchymal involvement causes a multitude of nonspecific CNS manifestations that can be confused with conditions such as multiple sclerosis, brain tumor, and psychiatric derangements. Manifestations of CNS parenchymal involvement in Lyme disease are generally associated, however, with a history of erythema chronicum migrans, meningitis, or carditis. Both second- and third-stage Lyme neuroborrelioses are commonly misdiagnosed because they are relatively uncommon and because they mimic many better-known disorders.

Entities:  

Mesh:

Year:  1989        PMID: 2682960

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  15 in total

1.  2012 integrative healthcare symposium: treating the pain of lyme disease and adopting lifestyle change as therapy.

Authors:  Walter Alexander
Journal:  P T       Date:  2012-04

Review 2.  Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications.

Authors:  G Wang; A P van Dam; I Schwartz; J Dankert
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

Review 3.  Psychiatric presentations/manifestations of medical illnesses.

Authors:  Jack Castro; Stephen Billick
Journal:  Psychiatr Q       Date:  2013-09

4.  Borrelia burgdorferi transcriptome in the central nervous system of non-human primates.

Authors:  Sukanya Narasimhan; Melissa J Caimano; Fang Ting Liang; Felix Santiago; Michelle Laskowski; Mario T Philipp; Andrew R Pachner; Justin D Radolf; Erol Fikrig; Melissa J Camaino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

5.  Comparison of polymerase chain reaction with culture and serology for diagnosis of murine experimental Lyme borreliosis.

Authors:  A R Pachner; N Ricalton; E Delaney
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

6.  Polymerase chain reaction primers and probes derived from flagellin gene sequences for specific detection of the agents of Lyme disease and North American relapsing fever.

Authors:  R N Picken
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

Review 7.  Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums.

Authors:  Vladimir V Bamm; Jordan T Ko; Iain L Mainprize; Victoria P Sanderson; Melanie K B Wills
Journal:  Pathogens       Date:  2019-12-16

Review 8.  Neuropsychological functioning in chronic Lyme disease.

Authors:  Holly James Westervelt; Robert J McCaffrey
Journal:  Neuropsychol Rev       Date:  2002-09       Impact factor: 6.940

9.  Lyme Neuroborreliosis Presenting as Multiple Cranial Neuropathies.

Authors:  Aishwarya Sriram; Samantha Lessen; Kevin Hsu; Cheng Zhang
Journal:  Neuroophthalmology       Date:  2021-07-23

10.  Anti-inflammatory effects of dexamethasone and meloxicam on Borrelia burgdorferi-induced inflammation in neuronal cultures of dorsal root ganglia and myelinating cells of the peripheral nervous system.

Authors:  Geeta Ramesh; Olivia C Meisner; Mario T Philipp
Journal:  J Neuroinflammation       Date:  2015-12-23       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.